Legal Opinion
Hirtenstein v. Cempra, Inc.
District Court, M.D. North Carolina
Decided October 26, 2018No. 16cv1303PublishedCited by 3 opinions
1Opinion of the Court
Thomas D. Schroeder, United States District Judge *536This is a putative federal securities class action on behalf of all persons1 who owned common stock of the biopharmaceutical company, Cempra, Inc. ("Cempra"), between July 7, 2015, and November 4, 2016 (the "class period"). In their amended complaint (Doc. 46), Plaintiffs seek recovery for stock losses under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 ("Exchange Act"), as amended by the Private Securities Litigation Reform Act of 1995 ("PSLRA") and Rule 10-b5 promulgated thereunder, 17 C.F.R. § 240.10b-5. The Defendants are…
2Cases cited40 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Erickson v. PardusSupreme Court of the United States · 2007
- Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
- Republican Party of North Carolina v. MartinCourt of Appeals for the Fourth Circuit · 1992
35 more not listed; retrieve them via the Exa API.
3Cited by3 opinions
- FISHER v. FENNEC PHARMACEUTICALS INC.District Court, M.D. North Carolina · 2022
- Gary Zagami, Individually and on Behalf of All Others Similarly Situated v. Wolfspeed, Inc., et al.District Court, M.D. North Carolina · 2026
- In re Sinclair Broadcast Group, Inc. Securities LitigationDistrict Court, D. Maryland · 2020